Marta Osrodek

The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62

Juan F. Linares, Tania Cid-Diaz, Ángeles Durán et al. · Cell Reports · 2022 · 69 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells

Mariusz L. Hartman, Michał Różański, Marta Osrodek et al. · Laboratory Investigation · 2017 · 32 citations · Full text

Life Sciences, Cell Biology, Oncology +12

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program

Małgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, Marta Osrodek et al. · Journal of Oncology · 2019 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +16

Physiologically Relevant Oxygen Concentration (6% O2) as an Important Component of the Microenvironment Impacting Melanoma Phenotype and Melanoma Response to Targeted Therapeutics In Vitro

Marta Osrodek, Mariusz L. Hartman · International Journal of Molecular Sciences · 2019 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAFV600E inhibitors in melanoma cells of different genetic subtypes

Aleksandra Mielczarek-Lewandowska, Małgorzata Sztiller-Sikorska, Marta Osrodek et al. · APOPTOSIS · 2019 · 20 citations · Full text

Life Sciences, Oncology, Pharmacology +17